Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Trump Warns Iran as Nationwide Protests Intensify and Internet Is Shut Down 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Trump Administration Targets Mortgage-Backed Securities to Ease Housing Affordability Crunch 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
EU Set to Approve Historic Mercosur Trade Deal Amid Farmer Protests 
Trump Administration Launches New DOJ Division to Fight Nationwide Fraud 
New York Sues Trump Administration Over Offshore Wind Project Freeze Impacting Clean Energy Goals 
Trump Signals Prolonged U.S. Control Over Venezuela, Dismisses Limits of International Law 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Trump Says U.S. Must Control Greenland to Counter Russia and China 
Trump to Attend World Economic Forum in Davos with Senior U.S. Officials 
G7 Finance Ministers to Meet in Washington on Critical Minerals Supply Chains 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
